Enveric Biosciences ENVB Stock
Enveric Biosciences Price Chart
Enveric Biosciences ENVB Financial and Trading Overview
| Enveric Biosciences stock price | 1.35 USD |
| Previous Close | 1.28 USD |
| Open | 1.3 USD |
| Bid | 0.99 USD x 200 |
| Ask | 1.63 USD x 200 |
| Day's Range | 1.26 - 1.41 USD |
| 52 Week Range | 1.26 - 17.64 USD |
| Volume | 250.66K USD |
| Avg. Volume | 3.91M USD |
| Market Cap | 5.36M USD |
| Beta (5Y Monthly) | 1.096 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -22.74 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | April 23, 2008 |
| 1y Target Est | N/A |
ENVB Valuation Measures
| Enterprise Value | -11863 USD |
| Trailing P/E | N/A |
| Forward P/E | -0.94326246 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 0.49608356 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | 0.001 |
Trading Information
Enveric Biosciences Stock Price History
| Beta (5Y Monthly) | 1.096 |
| 52-Week Change | -91.13% |
| S&P500 52-Week Change | 22.66% |
| 52 Week High | 17.64 USD |
| 52 Week Low | 1.26 USD |
| 50-Day Moving Average | 2.57 USD |
| 200-Day Moving Average | 4.49 USD |
ENVB Share Statistics
| Avg. Volume (3 month) | 3.91M USD |
| Avg. Daily Volume (10-Days) | 321.56K USD |
| Shares Outstanding | 4.03M |
| Float | 3.54M |
| Short Ratio | 0.06 |
| % Held by Insiders | 10.81% |
| % Held by Institutions | 2.77% |
| Shares Short | 26.58K |
| Short % of Float | 0.72% |
| Short % of Shares Outstanding | 0.72% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:12 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | March 31, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -96.72% |
| Return on Equity (ttm) | -183.11% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -8063011 USD |
| Net Income Avi to Common (ttm) | -11579979 USD |
| Diluted EPS (ttm) | -22.56 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 4.91M USD |
| Total Cash Per Share (mrq) | 1.33 USD |
| Total Debt (mrq) | 0 USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 11.668 |
| Book Value Per Share (mrq) | 2.681 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -8006800 USD |
| Levered Free Cash Flow (ttm) | -4908243 USD |
Profile of Enveric Biosciences
| Country | United States |
| State | MA |
| City | Cambridge |
| Address | 245 First Street |
| ZIP | 02142 |
| Phone | 617 444 8400 |
| Website | https://www.enveric.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 5 |
Enveric Biosciences, Inc., a biotechnology company, focuses on the development of small molecule neuroplastogenic therapeutics that address unmet needs in psychiatric and neurological disorders in the United States. Its lead drug candidate is EB-003, a novel derivative of DMT in preclinical development for mental health indications. The company also develops EVM401 series comprising novel phenylalkylamines and indolethylamines, as well as mescaline-derived compounds to target addiction and neuropsychiatric disorders; and Psybrary, a proprietary library. Enveric Biosciences, Inc. is headquartered in Cambridge, Massachusetts.
Q&A For Enveric Biosciences Stock
What is a current ENVB stock price?
Enveric Biosciences ENVB stock price today per share is 1.35 USD.
How to purchase Enveric Biosciences stock?
You can buy ENVB shares on the Tech Market Small exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Enveric Biosciences?
The stock symbol or ticker of Enveric Biosciences is ENVB.
Which industry does the Enveric Biosciences company belong to?
The Enveric Biosciences industry is Biotechnology.
How many shares does Enveric Biosciences have in circulation?
The max supply of Enveric Biosciences shares is 4.03M.
What is Enveric Biosciences Price to Earnings Ratio (PE Ratio)?
Enveric Biosciences PE Ratio is now.
What was Enveric Biosciences earnings per share over the trailing 12 months (TTM)?
Enveric Biosciences EPS is -22.74 USD over the trailing 12 months.
Which sector does the Enveric Biosciences company belong to?
The Enveric Biosciences sector is Healthcare.
Enveric Biosciences ENVB included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
{{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
US Tech Composite
IXIC
US
|
25587.04 USD — |
-2.21
|
13.85B USD — | 25513.26 USD — | 25882.57 USD — | — - | 13.85B USD — |
|
US Tech Health Care
IXHC
US
|
1184.66 USD — |
+0.75
|
— — | 1174.72 USD — | 1192.68 USD — | — - | — — |
- {{ link.label }} {{link}}